New Coronavirus (COVID19) Nuclear Protein.
Updated time: 2020-07-08 20:41:11
New Coronavirus (COVID19) Nuclear Protein.
Docket Number
28T-1090319
Announcement Date
2020-03-20
IP Status
Know-how
Abstract
We provide different subtypes of coronavirus nucleoprotein (N) for screening and can be used to rapidly produce detection antigens.
Technological Advantages
- Enhance sensitivity.
Applications of Technology
- Rapid coronavirus detection kits.
- Rapid general procedure in developing LFIA-based rapid detection tests (RIDTs).
- Rapid general procedure in developing diagnostic antibodies.
Inventor
An-Suei Yang
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

New Coronavirus (COVID19) Nuclear Protein.